Ebixa dosing made easier
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with moderate to severe Alzheimer's disease.
This site is intended for healthcare professionals
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with moderate to severe Alzheimer's disease.
The most up-to-date drug information at your fingertips.
A National Patient Safety Alert (NatPSA) has been issued...
EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...
EXCLUSIVE TO SUBSCRIBERS See the latest changes to...
EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...